← Eichor
Condition: Liver Biomarkers Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver Biomarkers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Nove
NA · 3 location(s) · Fundación Pública Andaluza para la gestión de la Investigaci · NCT07652151Evaluating Novel Therapies in ctDNA Positive GI Cancers
Phase 3 · 3 location(s) · Georgetown University · NCT05482516A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Phase N/A · 3 location(s) · Novartis Pharmaceuticals · NCT07683065Improving the Use of Immunotherapy to Treat Liver Cancer
NA · 4 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07623265Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05213598Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Phase N/A · 1 location(s) · Helse Stavanger HF · NCT01762813New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06906016PiMZ Longitudinal Cohort (PiMZ Logic)
Phase N/A · 5 location(s) · Columbia University · NCT06505603A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT07116486Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
Phase N/A · 1 location(s) · Asan Medical Center · NCT07186010MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT03178630Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06718517Identification of New Tools for Predicting Natural Metabolic Performance of the Liver
Phase 1 · 1 location(s) · Caroline Samer · NCT07014930Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Phase N/A · 1 location(s) · Danderyd Hospital · NCT07476703Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
NA · 1 location(s) · University Hospital, Rouen · NCT05375370Nottingham Community Liver Biomarkers Cohort
Phase N/A · 1 location(s) · University of Nottingham · NCT02037867Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT06382103HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiatio
NA · 1 location(s) · Montefiore Medical Center · NCT06899152Hepatocellular Carcinoma Identification Using Delta-HLD
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07148310A Prognostic Model for Drug-induced Liver Injury in China
Phase N/A · 13 location(s) · Beijing Friendship Hospital · NCT05060289Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With
Phase 3 · 3 location(s) · Beijing Shenogen Biomedical Co., Ltd · NCT05594927Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients
Phase N/A · 1 location(s) · The University of Hong Kong · NCT02434445On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Phase N/A · 2 location(s) · Region Skane · NCT05755672Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
NA · 4 location(s) · Hospices Civils de Lyon · NCT06567990"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepato
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05866783Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology
Phase N/A · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06095466The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel
Phase N/A · 4 location(s) · Javier Toledo · NCT06717295Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07523529Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07662356
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.